Sökning: WFRF:(Anastasia Athanasiadou) >
Karyotypic complexi...
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
-
- Blanco, Gonzalo (författare)
- Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain.;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain.;Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain.
-
- Puiggros, Anna (författare)
- Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain.;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain.
-
- Baliakas, Panagiotis (författare)
- Uppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab
-
visa fler...
-
- Athanasiadou, Anastasia (författare)
- G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece.;G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece.
-
- Garcia-Malo, MaDolores (författare)
- Hosp Univ Morales Meseguer, Serv Hematol, Murcia, Spain.
-
- Collado, Rosa (författare)
- Consorcio Hosp Gen Univ, Serv Hematol, Valencia, Spain.
-
- Xochelli, Aliki (författare)
- Uppsala universitet,Experimentell och klinisk onkologi,Science for Life Laboratory, SciLifeLab
-
- Rodriguez-Rivera, Maria (författare)
- Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain.;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain.
-
- Ortega, Margarita (författare)
- Hosp Valle De Hebron, Lab Citogenet, Barcelona, Spain.;Hosp Valle De Hebron, Serv Hematol, Barcelona, Spain.
-
- Jose Calasanz, Ma (författare)
- Univ Navarra, Dept Genet, Serv Citogenet, Pamplona, Spain.
-
- Luno, Elisa (författare)
- Hosp Univ Cent Asturias, Serv Hematol, Oviedo, Spain.
-
- Vargas, MaTeresa (författare)
- Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, UGC Hematol, Seville, Spain.
-
- Grau, Javier (författare)
- Univ Autonoma Barcelona, Inst Recerca Leucemia Josep Carreras IJC, ICO Hosp Germans Trias & Pujol, Serv Hematol, Badalona, Spain.
-
- Martinez-Laperche, Carolina (författare)
- Hosp GU Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Serv Hematol, Lab Genet Hematol, Madrid, Spain.
-
- Valiente, Alberto (författare)
- Complejo Hospitalario Navarra, Serv Genet & Hematol, Pamplona, Spain.
-
- Cervera, Jose (författare)
- Hosp Univ La Fe, Unidad Genet, Valencia, Spain.
-
- Anagnostopoulos, Achilles (författare)
- G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece.;G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece.
-
- Gimeno, Eva (författare)
- Hosp del Mar, Serv Hematol, Barcelona, Spain.
-
- Abella, Eugenia (författare)
- Hosp del Mar, Serv Hematol, Barcelona, Spain.
-
- Stalika, Evangelia (författare)
- CERTH, Inst Appl Biosci, Thessaloniki, Greece.
-
- Ma Hernandez-Rivas, Jesus (författare)
- Univ Salamanca, Hosp Univ Salamanca, Ctr Invest Canc, CSIC,Serv Hematol,IBSAL,IBMCC, Salamanca, Spain.
-
- Jose Ortuno, Francisco (författare)
- Hosp Univ Morales Meseguer, Serv Hematol, Murcia, Spain.
-
- Robles, Diego (författare)
- Hosp Txagorritxu, Serv Hematol, Vitoria, Spain.
-
- Ferrer, Ana (författare)
- Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain.;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain.
-
- Ivars, David (författare)
- Consorcio Hosp Gen Univ, Serv Hematol, Valencia, Spain.
-
- Gonzalez, Marcos (författare)
- Univ Salamanca, Hosp Univ Salamanca, Ctr Invest Canc, CSIC,Serv Hematol,IBSAL,IBMCC, Salamanca, Spain.
-
- Bosch, Francesc (författare)
- Hosp Valle De Hebron, Lab Citogenet, Barcelona, Spain.;Hosp Valle De Hebron, Serv Hematol, Barcelona, Spain.
-
- Abrisqueta, Pau (författare)
- Hosp Valle De Hebron, Lab Citogenet, Barcelona, Spain.;Hosp Valle De Hebron, Serv Hematol, Barcelona, Spain.
-
- Stamatopoulos, Kostas (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab,G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece.;G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece.;CERTH, Inst Appl Biosci, Thessaloniki, Greece.
-
- Espinet, Blanca (författare)
- Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain.;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain.
-
visa färre...
-
Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain.;Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain. Hosp del Mar, Serv Patol, Lab Citol Hematol, Lab Citogenet Mol, Barcelona, Spain.;Hosp del Mar, IMIM, Canc Res Programme, Grp Recerca Translac Neoplasies Hematol, Barcelona, Spain. (creator_code:org_t)
- 2016-11-04
- 2016
- Engelska.
-
Ingår i: Oncotarget. - : Impact Journals, LLC. - 1949-2553. ; 7:49, s. 80916-80924
- Relaterad länk:
-
https://uu.diva-port... (primary) (Raw object)
-
visa fler...
-
http://www.oncotarge...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, >= 3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10- year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Blanco, Gonzalo
-
Puiggros, Anna
-
Baliakas, Panagi ...
-
Athanasiadou, An ...
-
Garcia-Malo, MaD ...
-
Collado, Rosa
-
visa fler...
-
Xochelli, Aliki
-
Rodriguez-Rivera ...
-
Ortega, Margarit ...
-
Jose Calasanz, M ...
-
Luno, Elisa
-
Vargas, MaTeresa
-
Grau, Javier
-
Martinez-Laperch ...
-
Valiente, Albert ...
-
Cervera, Jose
-
Anagnostopoulos, ...
-
Gimeno, Eva
-
Abella, Eugenia
-
Stalika, Evangel ...
-
Ma Hernandez-Riv ...
-
Jose Ortuno, Fra ...
-
Robles, Diego
-
Ferrer, Ana
-
Ivars, David
-
Gonzalez, Marcos
-
Bosch, Francesc
-
Abrisqueta, Pau
-
Stamatopoulos, K ...
-
Espinet, Blanca
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Oncotarget
- Av lärosätet
-
Uppsala universitet